The May 2026 edition of IndiaTrialPulse by StriderDCT highlighted continued diversification in India’s multi-site clinical trial landscape, with Metabolic & Endocrinology emerging as the leading therapeutic area for the month. Built on insights from the Clinical Trials Registry of India
Expanding Tier 2 Participation Reshapes India’s Trial Ecosystem The April 2026 edition of IndiaTrialPulse by StriderDCT highlighted continued momentum in India’s multi-site clinical trial landscape, with increasing geographic participation and diversified therapeutic focus. Built on insights from the Clinical Trials
Multi-Site Momentum and Therapeutic Diversification Shape India’s Research Landscape The Q1 2026 edition of IndiaTrialPulse by StriderDCT analyzed how India’s clinical trial ecosystem evolved between January and March 2026. The quarter reflected growing multi-site momentum, strong domestic research participation, and
CNS and Oncology Continue to Drive Multi-Site Momentum The February 2026 edition of IndiaTrialPulse by StriderDCT tracked emerging trends from multi-site trials registered on the Clinical Trials Registry of India (CTRI). Key Highlights What This Indicates
Tracking the Pulse of Clinical Trials in India IndiaTrialPulse is a monthly clinical trial intelligence initiative by StriderDCT designed to decode emerging trends across India’s evolving clinical research ecosystem.Built using insights from the Clinical Trials Registry of India (CTRI), IndiaTrialPulse
